106-OR: A First-in-Human Single Ascending Dose Study of Oxyntomodulin Analog LY3305677 in Healthy Subjects
This multifaceted action addresses underlying metabolic dysfunction, not just symptoms, rendering these medications highly effective across diverse patient groups
Monday + Thursday) Total per week: 45 mg Aggressive loading (severe / acute injuries): 5 mg per injection , twice weekly = 10 mg/week Conservative loading (prevention / budget): 2.5 mg per injection , twice weekly = 5 mg/week Duration: 46 weeks Total peptide for standard loading: approximately 4050 mg (standard) or 80 mg (aggressive) TB-500 maintenance phase dosage Standard maintenance dose: 22.5 mg once weekly Reduced maintenance: 2 mg every 2 weeks (for long-term joint support) Duration: 48 weeks after loading
Rotating injection sites each week prevents tissue damage and scar formation, which can make future injections more difficult and increase vascular injury risk
Some of the potential medicines coming down the pipeline include: Survodutide , mazdutide , and pemvidutide , weekly injectable drugs that work on both GLP-1 and glucagon receptors to help reduce weight and lower blood sugar Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon that comes in a once-weekly injection Pramlintide and cagrilintide, injectable drugs that work by acting on receptors for amylin, a hormone produced by the pancreas that plays a role in blood sugar control and satiety (fullness) How long will I take weight loss medications
